ES2076178T3 - Papilomavirus humano tipo 57, su adn y las proteinas codificadas por el. - Google Patents

Papilomavirus humano tipo 57, su adn y las proteinas codificadas por el.

Info

Publication number
ES2076178T3
ES2076178T3 ES89114142T ES89114142T ES2076178T3 ES 2076178 T3 ES2076178 T3 ES 2076178T3 ES 89114142 T ES89114142 T ES 89114142T ES 89114142 T ES89114142 T ES 89114142T ES 2076178 T3 ES2076178 T3 ES 2076178T3
Authority
ES
Spain
Prior art keywords
dna
proteins coded
human papilomavirus
human
type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89114142T
Other languages
English (en)
Inventor
Villiers Ethel-Michele De
Anja Hirsch-Behnam
Hausen Harald Prof Dr Dr Zur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Application granted granted Critical
Publication of ES2076178T3 publication Critical patent/ES2076178T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

EL INVENTO DESCRIBE EL AISLAMIENTO DEL VIRUS DE PAPILLON HUMANO (HPV)57, EL CARACTERIZADO PARCIAL DE SU GENOMA, ASI COMO SU CLANADO EN PVC 19. DE ESTA FORMA SE ABRE EL CAMINO A DISAGNOSTICO DE TUMORES (ORALES, GENITALES Y DE PIEL), EN TANTO ESTEN ASOCIADOS CON EL PHV57.
ES89114142T 1988-08-06 1989-08-01 Papilomavirus humano tipo 57, su adn y las proteinas codificadas por el. Expired - Lifetime ES2076178T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3826793A DE3826793A1 (de) 1988-08-06 1988-08-06 Humaner papillomvirus typ 57, seine dna und die davon kodierten proteine

Publications (1)

Publication Number Publication Date
ES2076178T3 true ES2076178T3 (es) 1995-11-01

Family

ID=6360384

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89114142T Expired - Lifetime ES2076178T3 (es) 1988-08-06 1989-08-01 Papilomavirus humano tipo 57, su adn y las proteinas codificadas por el.

Country Status (9)

Country Link
US (3) US5187090A (es)
EP (1) EP0354440B1 (es)
JP (1) JP3016794B2 (es)
AT (1) ATE124991T1 (es)
AU (1) AU623424B2 (es)
CA (1) CA1339268C (es)
DE (2) DE3826793A1 (es)
ES (1) ES2076178T3 (es)
FI (1) FI98467C (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3722968A1 (de) * 1987-07-11 1989-01-19 Behringwerke Ag Humaner papillomvirus typ 41, seine dna und die dafuer kodierenden proteine
US5639871A (en) * 1988-09-09 1997-06-17 Roche Molecular Systems, Inc. Detection of human papillomavirus by the polymerase chain reaction
US5447839A (en) * 1988-09-09 1995-09-05 Hoffmann-La Roche Inc. Detection of human papillomavirus by the polymerase chain reaction
CA2365901A1 (en) * 1999-04-14 2000-10-19 Musc Foundation For Research Development Tissue-specific and pathogen-specific toxic agents and ribozymes
AU2003256325A1 (en) * 2002-06-26 2004-01-19 The Penn State Research Foundation Methods and materials for treating human papillomavirus infections
EP1664348B8 (en) 2003-09-25 2019-06-12 Third Wave Technologies, Inc. Detection of hpv
US8080643B2 (en) * 2006-09-05 2011-12-20 Third Wave Technologies, Inc. HPV primers
JP6153866B2 (ja) 2010-05-25 2017-06-28 キアゲン ガイサーズバーグ アイエヌシー． 迅速なハイブリッド捕捉アッセイ、及び関連する戦略的に切断されたプローブ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337336C (en) * 1987-05-26 1995-10-17 Attila T. Lorincz Human papillomavirus nucleic acid hybridization probes and methods for employing the same

Also Published As

Publication number Publication date
DE58909339D1 (de) 1995-08-17
EP0354440A1 (de) 1990-02-14
EP0354440B1 (de) 1995-07-12
US5187090A (en) 1993-02-16
JPH02150278A (ja) 1990-06-08
CA1339268C (en) 1997-08-12
US5618694A (en) 1997-04-08
AU3929589A (en) 1990-02-08
FI98467C (fi) 1997-06-25
DE3826793A1 (de) 1990-03-08
US6127164A (en) 2000-10-03
AU623424B2 (en) 1992-05-14
JP3016794B2 (ja) 2000-03-06
FI893683L (fi) 1990-02-07
FI893683A0 (fi) 1989-08-03
ATE124991T1 (de) 1995-07-15
FI98467B (fi) 1997-03-14

Similar Documents

Publication Publication Date Title
ES2039233T5 (es) Procedimientos para la produccion de glicoproteinas del citomegalovirus humano (hcmv), anticuerpos correspondientes y vacunas del hcmv, y vectores recombinantes para los mismos.
DE69738074D1 (de) Reinigung von neurotrophinen
DK0409472T3 (da) Knoglemorfogenetisk protein
DE69020151D1 (de) Genetisch geformte neue pflanzenphenotypen.
ATE407949T1 (de) Charakterisierung der proteinfamilie von soc/crac kalziumkanälen
EP0273716A3 (en) Synthetic peptides which induce cellular immunity to the aids virus and aids viral proteins
FI950887A7 (fi) MAGE-3-geenistä peräisin oleva ja HLA-A1-proteiinin tarjoama eristetty nonapeptidi ja sen käytöt
PT917571E (pt) Gene relacionado com agouti
IT8723261A0 (it) Innaffiatoio del tipo ondeggiante oscillante regolabile.
ES2076178T3 (es) Papilomavirus humano tipo 57, su adn y las proteinas codificadas por el.
DE3672950D1 (de) Thymusextraktfraktionen enthaltende pharmazeutische zusammensetzung.
DK0601154T3 (da) BPC-peptider, deres fremstilling og anvendelse
ATE190352T1 (de) Dorsalgewebe beeinflussender faktor und zusammensetzungen
ES545725A0 (es) Procedimiento para preparar peptidos de interferon
ES2006476A6 (es) Un procedimiento para obtener interleukin-2 humana
ES2058479T3 (es) Compuestos peptidicos.
DE69921180D1 (de) Künstliche matrix-anheftungsregion zur erhöhung der expression von in pflanzen eingeführten genen
DE3785526D1 (de) Auf druck ansprechende schalter erhoehter langlebigkeit.
ATE353913T1 (de) Neue collectine
PT714441E (pt) Alergenios recombinantes de cladosporium herbarum
EP1007647A4 (en) PRODUCTION OF THE INGAP PROTEIN WITH A HIGH EXPRESSION RATE
FI885301A7 (fi) Tekijä VIII:n puhdistuksessa käyttökelpoisia peptidejä
ATE275207T1 (de) Dna zur abschätzung des progressionspotentials von zervixläsionen
DE60139458D1 (de) Neue menschliche g-protein gekoppelten rezeptoren und dafür kodierende polynucleotide
Marusic Purification of specific DNA binding proteins from human cells

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 354440

Country of ref document: ES